Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is the third most common cancer worldwide with a high mortality rate at the advanced stages. However, colorectal cancer is not a single type of tumor; its pathogenesis depends on the anatomical location of the tumor and differs between right side and left side of the colon. Tumors in the proximal colon (right side) and distal colon (left side) exhibit different molecular characteristics and histology. In the right-sided tumors, mutations in the DNA mismatch repair pathway are commonly observed; and these tumors generally have a flat histology. In the left-sided tumors, chromosomal instability pathway-related mutations, such as KRAS, APC, PIK3CA, p53 mutations are observed and these tumors demonstrate polypoid-like morphology. Therapy responses are totally different between these tumor entities. Left-sided colorectal cancer (LCRC) patients benefit more from adjuvant chemotherapies such as 5-fluorouracil (5-FU)-based regimes, and targeted therapies such as anti- epidermal growth factor receptor (EGFR) therapy, and have a better prognosis. Right-sided colorectal cancer (RCRC) patients do not respond well to conventional chemotherapies, but demonstrate more promising results with immunotherapies because these tumors have high antigenic load. For the development of effective therapy regimes and better treatment options, it is essential to evaluate right-sided and left-sided tumors as separate entities, and design the therapy regime considering the differences between these tumors. Gastroenterol Res. 2018;11(4):264-273 doi: https://doi.org/10.14740/gr1062w
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Right-sided tumors more commonly exhibit DNA mismatch repair deficiencies, while left-sided tumors often have mutations in KRAS, APC, PIK3CA, and p53 [30].”
From Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · cited 1×
“highly use these regulators as an anti-tumor immune response [82, 83].”
BackgroundA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“In this model, carcinogenesis begins with the inactivation or deletion of adenomatous polyposis coli (APC) tumor suppressor gene, followed by the activation of Kirsten ras homolog (KRAS) oncogene, the inactivation of p53 tumor suppressor gene and other mutations [47, 48].”
MethodPD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · cited 1×
“Metastatic melanoma is one of the tumors with high immunogenic load and melanoma patients are highly benefiting from anti-CTLA-4 and anti-PD-1 therapies [87, 88].”
BackgroundGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728 · cited 1×
“In this model, carcinogenesis begins with the inactivation or deletion of adenomatous polyposis coli (APC) tumor suppressor gene, followed by the activation of Kirsten ras homolog (KRAS) oncogene, the inactivation of p53 tumor suppressor gene and other mutations [47, 48].”
MethodType, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516 · cited 4×
“Presence of T cells in these tumors is associated with better prognosis and less frequent metastasis [12, 13, 24].”
BackgroundInfluentialImmune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229 · cited 1×
“Interestingly, tumor infiltrating lymphocytes express high level of PD-L1, which is thought to be a result of chronic stimulation because of the neoantigen load [86].”
Background
Cited by
Items 101–200 of 581
Bodalal, Z., Hong, E. K., Trebeschi, S., Kurilova, I., Landolfi, F., Bogveradze, N., Castagnoli, F., Randon, G., Snæbjörnsson, P., Pietrantonio, F., et al. (2024) · European Radiology Experimental · doi:10.1186/s41747-024-00484-8 · Cited by 25
“The patient characteristics in both our training and validation sets aligned with the general CRC population, showing a higher prevalence of MSI in the right colon, as reported in previous studies [57].”
ResultPan-cancer spatial atlas of tertiary lymphoid structures
Cho, K. S., Liu, Y., Pei, G., Chen, J., Dai, Y., Liu, Y., Zhou, T., Bougoüin, A., Serrano, A., Wani, K., et al. (2026) · Science · doi:10.1126/science.adz2742 · Cited by 28
Alsalman, A., Al-Mterin, M. A., Abu-Dayeh, A., Alloush, F., Murshed, K., & Elkord, E. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050816 · Cited by 21
“Disease stage and anatomical status are important factors in determining disease progression and overall survival (OS) of CRC patients [4,21,22].”
BackgroundResultInfluentialBraitmaier, M., Schwarz, S., Kollhorst, B., Senore, C., Didelez, V., & Haug, U. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.05.024 · Cited by 22
Du, X., Qi, H., Ji, W., Li, P., Hua, R., Wen-liang, H., & Qi, F. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/9408839 · Cited by 27
Dichotomous colorectal cancer behaviour
Aljama, S., Lago, E. P., Zafra, O., Sierra, J., Simón, D., Santos, C., Rodríguez-Pascual, J., & Garcia‐Romero, N. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104067 · Cited by 26
“…and oxaliplatin through activation of autophagy and inhibition of apoptosis through the expression of Baculoviral IAP Repeat Containing 3(BIRC3) (Zhang et al., 2019), which could be related with the worse response to 5-FU in right-sided CRC patients compared to left-sided (Baran et al., 2018) (Fig.”
Activation of cGAS-STING Pathway Is Associated with MSI-H Stage IV Colorectal Cancer
Kunac, N., Degoricija, M., Viculin, J., Omerović, J., Terzić, J., Vilović, K., & Korać-Prlić, J. (2022) · Cancers · doi:10.3390/cancers15010221 · Cited by 21
“Patients with right CRC typically have tumours with a higher rate of microsatellite instability (MSI), whereas patients with left CRC have tumours with a higher rate of chromosomal instability [29].”
BackgroundTissue-resident microbiota impacts colorectal cancer progression and prognosis
Shi, Z., Ren, H., Lin, C., Li, F., Wu, M., Yang, F., Luo, T., Nunes, L., Isaksson, A., Hammarström, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67047-2 · Cited by 25
Insights on Ferroptosis and Colorectal Cancer: Progress and Updates
Hu, B.-L., Yin, Y., Li, S., & Guo, X. (2022) · Molecules · doi:10.3390/molecules28010243 · Cited by 20
“Left-sided CRCs benefit more from adjuvant chemotherapy regimes and targeted therapies; rightsided CRCs do not respond well to conventional chemotherapies, but they show promising results with immunotherapies [91].”
BackgroundWaldstein, S., Spengler, M., Pinchuk, I. V., & Yee, N. S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071114 · Cited by 22
“In contrast, the left-sided CRC is often tubular villous, polypoid, and with a low immunogenic component [8].”
BackgroundIchisaka, Y., Yano, S., Nishimura, K., Niwa, T., & Shimizu, H. (2024) · Biomedical Research · doi:10.2220/biomedres.45.57 · Cited by 23
Ahn, H., Lee, J. W., Jang, S., Lee, H. J., Lee, J., Oh, M., & Lee, S. M. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.110047 · Cited by 20
Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
Blad, N., Palmqvist, R., & Karling, P. (2022) · BMC Cancer · doi:10.1186/s12885-022-09440-4 · Cited by 24
“[24], the differences between left-sided and right-sided CRC were investigated.”
Osorio, D., Capasso, A., Eckhardt, S. G., Giri, U. P., Somma, A. J., Pitts, T. M., Lieu, C. H., Messersmith, W. A., Bagby, S. M., Singh, H., et al. (2024) · Nature Computational Science · doi:10.1038/s43588-024-00597-5 · Cited by 27
“It is well recognized that the origin, phenotype, and prognosis of cancer arising from different sides of patients’ intestines vary (61).”
BackgroundJain, A. K., Morris, M. T., Berardi, D., Arora, T., Domingo-Almenara, X., Paty, P. B., Rattray, N. J. W., Kerekes, D. M., Lu, L., Khan, S. A., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02133-5 · Cited by 20
“Evidence suggests that embryological, histological, genetic, molecular, and immunological characteristics of CRC differ by anatomic subsite defined as right-sided CRC (RCC), left-sided CRC (LCC), and rectal cancer [2], which supports the classification of CRC as three distinct tumor entities [2, 3].”
BackgroundRico, S. D., Höflmayer, D., Büscheck, F., Dum, D., Luebke, A. M., Kluth, M., Hube‐Magg, C., Hinsch, A., Möller‐Koop, C., Perez, D. R., et al. (2020) · Medical Molecular Morphology · doi:10.1007/s00795-020-00274-2 · Cited by 19
“A gradual change of biomarker expression from proximal to distal colon could, for example, be explained by continuing changes in the density and the composition of the stool, and the exposure time to different carcinogenic factors during the colon passage or be related to the embryonal development of the colon (summar…”
BackgroundmiR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy
Nguyen, K., Lindebjerg, J., Kalmár, A., Molnar, B. A., Sørensen, F. B., Hansen, T. F., & Nielsen, B. S. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9945-3 · Cited by 20
Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer
Batra, A., Rigo, R., Hannouf, M. B., & Cheung, W. Y. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.09.006 · Cited by 21
Peixoto, C., Lopes, M. B., Martins, M., Casimiro, S., Sobral, D., Grosso, A. R., Abreu, C., Macedo, D., Costa, A. L., Pais, H. L., et al. (2023) · BMC Bioinformatics · doi:10.1186/s12859-022-05104-z · Cited by 20
“However, for DATASET1 and DATASET2, there was a tendency for the right side to be related with worst survival probability, as shown in the literature [42].”
ResultLiu, Q., Sadr‐Azodi, O., Engstrand, L. G., Fall, K., & Brusselaers, N. (2024) · Helicobacter · doi:10.1111/hel.70001 · Cited by 21
“…cancer were potentially higher than for left-sided colorectal cancer may suggest detection bias is less of a concern as left-sided colon cancer is easier to detect due to its clinical symptoms [54, 55], and might be explained by its closers anatomical proximity to the upper gastrointestinal tract.”
Guo, D., Li, X., Xie, A., Cao, Q., Zhang, J., Zhang, F., Li, W., & Chen, J. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23132 · Cited by 20
Saadat, L. V., Boerner, T., Goldman, D. A., Gönen, M., Frankel, T. L., Vakiani, E., Kingham, T. P., Jarnagin, W. R., Wei, A. C.-C., Soares, K. C., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08862-3 · Cited by 18
Lunkka, P., Malila, N. K., Ryynänen, H., Heikkinen, S. M. M., Sallinen, V. J., & Koskenvuo, L. E. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1867893 · Cited by 18
“This is of high importance according to recent data regarding putative differential mechanisms and prognoses of right- and left-sided tumours [16].”
BackgroundFernández, I. M., Velasco, S. M., Luque, J. D. T., Poveda, I. G., López, M. R., & Santoyo, J. S. (2021) · Cancers · doi:10.3390/cancers13112647 · Cited by 18
“A recent review emphasized the differences between tumors in the proximal (right side) and distal (left side) colon because they present different molecular and histological characteristics that determine the treatments to be used and, therefore, the effectiveness of chemotherapy treatments [10].”
BackgroundNagai, Y., Kiyomatsu, T., Gohda, Y., Otani, K., Deguchi, K., & Yamada, K. (2021) · Global Health & Medicine · doi:10.35772/ghm.2020.01096 · Cited by 18
Li, C., Wang, Z., Ding, P., Zhou, Z., Chen, R., Hu, Y., Zhao, K., Peng, W. J., Yang, X., Sun, N., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c15056 · Cited by 18
Kalidindi, A. V., Dubashi, B., Jayanthi, M., & Shewade, D. G. (2020) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_618_19 · Cited by 17
Hata, N., Shigeyasu, K., Umeda, Y., Yano, S., Takeda, S., Yoshida, K., Fuji, T., Yoshida, R., Yasui, K., Umeda, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29397-z · Cited by 17
Tang, J., Lam, G. T., Brooks, R. D., Miles, M. A., Useckaite, Z., Johnson, I. R., Ung, B. S. ‐., Martini, C., Karageorgos, L., Hickey, S. M., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216639 · Cited by 19
Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer
Ho, V., Chung, L., Wilkinson, K. J., Ma, Y., Rutland, T., Lea, V., Lim, S. H.-S., Abubakar, A., Ng, W. L., Lee, M. T., et al. (2024) · Cancers · doi:10.3390/cancers16112005 · Cited by 23
“Numerous studies have shown that tumors arising within the right (proximal) and left (distal) sides of the colorectum are histologically, molecularly, and clinically distinct, likely due to the differing physiological features of these two anatomic regions [38–44].”
BackgroundOffermans, K., Reitsam, N. G., Simons, C. C. J. M., Grosser, B., Zimmermann, J., Grabsch, H. I., Märkl, B., & van den Brandt, P. A. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00349-z · Cited by 17
“It is known that right sided colon cancer is more aggressive and biologically distinct [47], leading also to differences in treatment response between right and left sided colon cancer [48, 49].”
BackgroundSurvival effect of probiotics in a rat model of colorectal cancer treated with capecitabine
Gigola, G., Carriere, P., Díaz, M. B. N., Perdigón, G., Zwenger, A. O., & Gentili, C. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1518 · Cited by 17
Niederseer, D., Bracher, I., Stadlmayr, A., Huber-Schönauer, U., Plöderl, M., Obeid, S., Schmied, C. M., Hammerl, S., Stickel, F., Lederer, D., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120484 · Cited by 17
“More recent studies demonstrating the clinical, histopathological, and molecular differences have supported this theory [7].”
ResultYates, J., Schaufelberger, H., Steinacher, R., Schär, P., Truninger, K., & Boeva, V. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae016 · Cited by 16
“This observation aligns with epidemiological data indicating proximal CRC risk increases with age, whereas lifestyle exposure drives left-sided and rectal CRC in younger patients (59).”
ResultGene Alterations of N6‐Methyladenosine (m6A) Regulators in Colorectal Cancer: A TCGA Database Study
Zhang, Q., Cai, Y. A., Kurbatov, V., Khan, S. A., Lu, L., Zhang, Y., & Johnson, C. H. (2020) · BioMed Research International · doi:10.1155/2020/8826456 · Cited by 16
“Left-sided colon cancer (LCC) harbors more chromosomal instability pathway-related mutations, including APC, KRAS, and P53 mutations, while MSI and DNA mismatch repair pathways are commonly observed in the right-sided tumors (RCC) [41].”
Yan, X., Wang, K., Bao, Q., Wang, H., Jin, K., Wang, J., & Xing, B.-C. (2021) · BMC Surgery · doi:10.1186/s12893-021-01286-0 · Cited by 16
Saravani, K., Salarzaei, M., & Parooie, F. (2021) · Human Antibodies · doi:10.3233/hab-210451 · Cited by 16
Benson, K. R. K., Sandhu, N., Zhang, C., Ko, R. B., Toesca, D. A. S., Lee, P. E., von Eyben, R., Diehn, M., Gensheimer, M. F., Maxim, P. G., et al. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000864 · Cited by 16
“7-207) 12 (2-52) Pre-SABR months on chemotherapy, median (range) 9 (0-14) 13 (0-60) 10 (0-33) 8 (0-40) 7 (0-36) Post-SABR months on chemotherapy, median (range) 0 (0-37) 0 (0-20) 0 (0-6) 0 (0-34) 0 (0-37)”
Harewood, R., Wooldrage, K., Robbins, E. C., Kinross, J. K., von Wagner, C., & Cross, A. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01719-4 · Cited by 17
“…CRC by subsite, it is important to determine whether associations between adenoma characteristics and CRC differ by subsite to better understand the lower effectiveness of colonoscopy at reducing the incidence of cancer in the proximal colon compared to distal colon and rectal subsites [17 – 22].”
Masuelli, S., Real, S., Campoy, E., Branham, M. T., Marzese, D. M., Salomon, M. P., Blas, G. A. D., Arias, R., Levin, M. G., & Roqué, M. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00440-5 · Cited by 16
Joharatnam‐Hogan, N., Wilson, W., Shiu, K., Fusai, G., Davidson, B. R., Hochhauser, D., Bridgewater, J. A., & Khan, K. H. (2020) · Cancers · doi:10.3390/cancers12123545 · Cited by 16
Harewood, R., Disney, R., Kinross, J. K., von Wagner, C., & Cross, A. J. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01472-8 · Cited by 18
Malla, M., Deshmukh, S. K., Wu, S. K., Samec, T., Olevian, D. C., Naili, R. E., El‐Rayes, B. F., Xiu, J., Farrell, A. P., Lenz, H., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00816-1 · Cited by 16
Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002–09 and 2010–17
Lee, S. H. F., Rahman, H. A., Abidin, N., Ong, S. K., Leong, E., & Naing, L. (2021) · BMC Cancer · doi:10.1186/s12885-021-08224-6 · Cited by 15
KRAS Mutational Profiles among Colorectal Cancer Patients in the East Coast of Peninsular Malaysia
Hasbullah, H. H., Sulong, S., Jalil, N. A. C., Aziz, A. A. A., Musa, N., & Musa, M. (2023) · Diagnostics · doi:10.3390/diagnostics13050822 · Cited by 16
Long-term Outcomes of Robot-assisted Versus Laparoscopic Surgery for Colon Cancer
Cuk, P., Kaalby, L., Deding, U., Al‐Najami, I., & Ellebæk, M. B. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006110 · Cited by 14
“28,29 This has been con fi rmed by large registry-based nationwide cohort studies 29,30 and a meta-analysis including approximately 1.5 million patients demonstrating a signi fi cantly reduced risk of death from left-sided colon cancer.”
BackgroundInfluentialAllan, Z., Liu, D. S., Lee, M., Tie, J., & Clemons, N. J. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvad188 · Cited by 14
Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases
Bergen, E. S., Scherleitner, P., Ferreira, P., Kiesel, B., Müller, C., Widhalm, G., Dieckmann, K. U., Prager, G. W., Preusser, M., & Berghoff, A. S. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100168 · Cited by 15
“Significant underlying molecular differences could be identified, since right-sided tumors are highly immunogenic characterized by higher rates of MMR deficiency as well as BRAF mutations and exhibit a higher incidence of activated RAS and PIK3CA mutations.(7,8) Moreover, the microbial richness was shown to increase f…”
BackgroundZhao, B., Lopez, N., Eisenstein, S. G., Schnickel, G. T., Sicklick, J. K., Ramamoorthy, S. L., & Clary, B. M. (2019) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2019.12.002 · Cited by 14
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
Aggarwal, H., Sheffield, K. M., Li, L., Lenis, D., Sorg, R. A., Barzi, A., & Miksad, R. A. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i4.405 · Cited by 14
Monocyte response after colorectal surgery: A prospective cohort study
Edomskis, P. P., Dik, W. A., Sparreboom, C. L., Nagtzaam, N. M. A., van Oudenaren, A., Lambrichts, D. P. V., Bayon, Y., van Dongen, N. N. N., Menon, A. G., de Graaf, E. J. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1031216 · Cited by 16
“Moreover right-sided colorectal tumors are commonly microsatellite-instable tumors, whereas left-sided tumors are more often chromosomal-instable (29).”
BackgroundIntroducing Neoadjuvant Immunotherapy for Colorectal Cancer: Advancing the Frontier
Orhan, A., Justesen, T. F., Raskov, H., Qvortrup, C., & Gögenür, I. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006443 · Cited by 14
“36 Also, a greater proportion of dMMR tumors are found on the right side of the colon.”
Bharti, A., Ajinkya, K., Markus, M. A., Ramos‐Gomes, F., Bohnenberger, H., Ströbel, P., Alves, F., & Klein, O. (2024) · npj Imaging · doi:10.1038/s44303-024-00041-3 · Cited by 13
“The prognosis and response to treatment in CRC patients vary depending on the anatomical origin of the primary tumour, i.e., whether it derived from the left side or the right side of the colon 57 .”
Pallatt, S., Nambidi, S., Adhikary, S., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2025) · Oncology Reviews · doi:10.3389/or.2025.1549416 · Cited by 14
Min, S. T., Roohullah, A., Tognela, A., Jalali, A., Lee, M., Wong, R., Shapiro, J. D., Burge, M., Yip, D., Nott, L. M., et al. (2021) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13553 · Cited by 14
Mukkamalla, S. K. R., Huynh, D. V., Somasundar, P. S., & Rathore, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.568417 · Cited by 14
Perea, J., García, J. L., Corchete, L. A., Tapial, S., López, S. O., López, A. V., García‐Olmo, D., Urioste, M., Goel, A., & González‐Sarmiento, R. (2021) · Scientific Reports · doi:10.1038/s41598-020-79118-z · Cited by 13
Sacdalan, D. L., Garcia, R. L., Diwa, M. H., & Sacdalan, D. B. (2021) · Cancer Management and Research · doi:10.2147/cmar.s286618 · Cited by 13
Boka, H. J., Engel, R. M., Georges, C., McMurrick, P. J., & Abud, H. E. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02327-5 · Cited by 14
Construction of ceRNA Coexpression Network and Screening of Molecular Targets in Colorectal Cancer
Hui, Z., Wang, Z., Yang, X., Jin, L., Jing, Z., & Han, S. (2020) · Disease Markers · doi:10.1155/2020/2860582 · Cited by 12
Dolci, M., Favero, C., Tarantini, L., Villani, S., Bregni, M., Signorini, L., Valle, A. D., Crivelli, F., D’Alessandro, S., Ferrante, P., et al. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00662-6 · Cited by 12
NFκB signalling in colorectal cancer: Examining the central dogma of IKKα and IKKβ signalling
McKenzie, M., Lian, G., Pennel, K. A. F., Quinn, J. A., Jamieson, N. B., & Edwards, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32904 · Cited by 12
“…between disease sites can drive different prognoses and effectiveness of treatment; with rectal cancers more likely to benefit from neoadjuvant therapy [13], and right-sided colon cancer, associated with an immune cell rich environment, demonstrating the poorest patient outcome in CRC [14].”
Aldoori, J., Zulyniak, M. A., Toogood, G. J., & Hull, M. A. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1154 · Cited by 11
Chikaishi, Y., Matsuoka, H., Sugihara, E., Takeda, M., Sumitomo, M., Yamada, S., Inaguma, G., Omura, Y., Cheong, Y., Kobayashi, Y., et al. (2025) · Cancer Science · doi:10.1111/cas.16455 · Cited by 13
“In addition to mutation frequencies, right-sided and left-sided colon tumors differ according to adenoma type [8], morphology [9], immune cell infiltration and response to immunogens [10, 11], metastasis sites [12], age and sex association [11], prognosis at various stages [13], and the effects of…”
Mid-transverse Location in Primary Colon Tumor: A Poor Prognostic Factor?
Zenger, S., Gürbüz, B., Can, U., Erginöz, E., Özata, İ. H., Kulle, C. B., Balık, E., & Buğra, D. (2021) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002083 · Cited by 11
Hamed, A. B., Shuai, Y., Derby, J., Holtzman, M. P., Ongchin, M. C., Bartlett, D. L., Pingpank, J. F., Pai, R. K., Singhi, A. D., & Choudry, H. A. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13463-x · Cited by 12
“PCI, median (IQR) 12 (11) 12 (11) 12 (11.”
Signorelli, C., Chilelli, M. G., Sperduti, I., Giacinti, S., Amodio, P. M., PALMIERI, R. M., Ranalli, T. V., Gomes, V., Rosetto, M. E., Nelli, F., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13679 · Cited by 11
Lai, H., Wei, J. C., Hung, H., & Lin, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-56512-w · Cited by 11
Ounissi, D., Weslati, M., Boughriba, R., Hazgui, M., & Bouraoui, S. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2003-42 · Cited by 14
Kastora, S. L., Osborne, L. L., Jardine, R., Kounidas, G., Carter, B., & Myint, P. K. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.05.040 · Cited by 12
“Multiple meta-analyses have provided conflicting evidence regarding NSAID use and AL rates [33-38].”
BackgroundDai, Y., Fang, C., Yang, H., Jian, Y., Wang, S., & Liu, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254000 · Cited by 11
“Histology and molecular features of right-sided (proximal) colon cancers are different when compared with left-sided (distal) colon cancers and rectal cancers [22].”
BackgroundColorectal Cancer Among Farmers in the Agrican Cohort Study
Talibov, M., Tual, S., Morlais, F., Meryet‐Figuière, M., Boulanger, M., Bouvier, V., Perrier, S., Clin, B., Baldi, I., Lebailly, P., et al. (2021) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102125 · Cited by 12
“Although several studies considered CRC as a single group, right and left colon cancer display different characteristics at the molecular, mutational and histological levels, and have different prognosis and responses to therapy (36).”
InfluentialPirozzi, B. M., Siragusa, L., Baldini, G., Pellicciaro, M., Grande, M., Efrati, C., Finizio, R., Formica, V., Blanco, G. D. V., & Sica, G. S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041425 · Cited by 11
“Many studies demonstrated that advanced left-sided cancers (including rectal cancer) decreased after the endoscopic screening protocol introduction while right-sided cancers have a lower decrease [42,43].”
BackgroundRamos-Esquivel, A., Rodriguez-Porras, L., & Juan, P. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101680 · Cited by 13
Minimally invasive complete mesocolic excision for right colon cancer
Park, H., Lee, T., & Kim, S. H. (2020) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12331 · Cited by 11
Differences in the on- and off-tumour microbiota between right- and left-sided colorectal cancerPreprint
Phipps, O., Quraishi, M. N., Dickson, E. A., Segal, J. P., Steed, H., Kumar, A., Acheson, A. G., Beggs, A. D., Brookes, M., & Al-Hassi, H. O. (2021) · doi:10.21203/rs.3.rs-226410/v1 · Cited by 11
Erkinantti, S., Hautakoski, A., Sund, R., Arffman, M., Urpilainen, E., Puistola, U., Jukkola‐Vuorinen, A., Karihtala, P., & Läärä, E. (2022) · Cancer Control · doi:10.1177/10732748221134090 · Cited by 10
“Cancers of the left- and right-side colon differ in their physiological characteristics and in their genetic basis.(18,52) Their prognosis therefore also differs, and treatment in the metastatic setting also varies.”
BackgroundMethodTargeting the gut and tumor microbiome in cancer treatment resistance
Čierniková, S., Ševčíková, A., & Mego, M. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00201.2024 · Cited by 12
Alampritis, G., Thoukididou, S. N., Ramos, M., Georgiou, P., Kalofonou, M., & Simillis, C. (2025) · International Journal of Colorectal Disease · doi:10.1007/s00384-025-04904-y · Cited by 11
“CRC is a heterogenous disease with several carcinogenic pathways exhibiting a variety of genetic and epigenetic alterations [13].”
Seoane, A., Saperas, E., Castella, E. O., Pera-Román, M., Gil, A. R., Riu, F., Priego, L. B., Dedéu, J. M., Sánchez, M. Á. P., Bessa, X., et al. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.5701/2018 · Cited by 10
Gilad, O., Rosner, G., Wajcman, D. I., Zur, R., Rosin‐Arbesfeld, R., Gluck, N., Strul, H., Lehavi, D., Rolfe, V. E., & Kariv, R. (2022) · Genes · doi:10.3390/genes13122182 · Cited by 10
“descending and sigmoid colon of FAP patients [50], and conventional chemotherapies and targeted therapies are more effective in left-sided CRC, while MSI-high tumors, which are more common in the right colon, benefit more from immunotherapies [51].”
BackgroundIsoperistaltic vs antiperistaltic anastomosis after right hemicolectomy: A comprehensive review
Symeonidis, D., Karakantas, K.-S., Kissa, L., SAMARA, A. A., Bompou, E., Tepetes, K., & Tzovaras, G. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i8.1694 · Cited by 10
Gudiño, R. C., McManus, K. J., & Hombach‐Klonisch, S. (2023) · Cancers · doi:10.3390/cancers15061735 · Cited by 12
“Clinical and genetic studies have established clear differences in the molecular determinants, histology, progression and survival between tumors arising in the different anatomical regions (reviewed in [3,45,46]).”
BackgroundInfluentialTabernero, J. M., Yoshino, T., Stintzing, S., de Gramont, A., Gibbs, P., Jonker, D. J., Nygren, P., PAPADIMITRIOU, C. A., Prager, G. W., Tell, R., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0361 · Cited by 10
“Both factors are associated with greater clinical benefit from 5-FU–based treatment (18, 19), andthismaybesynergisticallyenhancedwithanactivefolate.”
Bingmer, K. E., Ofshteyn, A., Bliggenstorfer, J. T., Kethman, W. C., Ammori, J. B., Charles, R., Stein, S. L., & Steinhagen, E. F. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26061 · Cited by 10
Herold, Z., Acs, M., Szász, A. M., Olasz, K., Hussong, J., Mayr, M., Dank, M., & Piso, P. (2022) · Cancers · doi:10.3390/cancers14163978 · Cited by 10
“Right-sided and left-sided tumors were defined as originating from the cecum, ascending colon, and proximal two-thirds of the transverse colon and from the distal one-third of the transverse colon, descending, and sigmoid colon, respectively [17].”
BackgroundPerfil Clínico-Epidemiológico do Câncer Colorretal na Região Oeste do Paraná, Brasil, 2016-2018
Pucci, M. D., Dasenbrock, A., Tanzawa, C. K., & dos Santos, M. B. (2023) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2023v69n1.3143 · Cited by 17
“Em análise de Baran et al. 20 , são elucidadas as diferenças entre tumores localizados nos cólons direito e esquerdo, corroborando os achados desta casuística com relação a sexo e à média de idade dos pacientes em cada topografia, em avaliação isolada dos grupos.”
BackgroundZhang, T., Song, Z., Zhang, Y., Ji, X., Jing, X., Shi, Y. Y., Cheng, X., & Zhao, R. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-221 · Cited by 9
“Lymph node harvest, median [IQR], n 18 [6] 15 [8] 0.”
Banks, J. N., Rashid, A., Wilson, T., Challand, C. P., & Lee, M. J. (2024) · Annals of The Royal College of Surgeons of England · doi:10.1308/rcsann.2024.0056 · Cited by 9
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer
Roberto, M., Arrivi, G., Bianco, F. L., Cascinu, S., Gelsomino, F., Caputo, F., Cerma, K., Ghidini, M., Ratti, M., Pizzo, C., et al. (2020) · Cancers · doi:10.3390/cancers12092457 · Cited by 9
“However, the difference between these tumors can be attributed to a combination of anatomical and developmental origin, as well as distinct carcinogenic factors [1].”
BackgroundMalik, A., Bhatia, J. K., Sahai, K., Boruah, D., & Sharma, A. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.03.024 · Cited by 9
Gao, Y., Byrd, D. A., Prizment, A. E., Lazovich, D., & Bostick, R. M. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1952629 · Cited by 9
“CRC pathogenesis may differ somewhat by colorectal site (63).”
BackgroundGuo, J., Xia, T.-Y., Deng, S.-H., Xue, W., Cui, B., & Liu, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.668888 · Cited by 10
“The RCC tumors arise from ascending colon, and proximal twothirds of the transverse colon and the LCC tumors arise from the descending and sigmoid colon and distal one-third of the transverse colon (Baran et al., 2018).”
BackgroundWrana, F., Dötzer, K., Prüfer, M., Werner, J., & Mayer, B. (2022) · Cancers · doi:10.3390/cancers14081939 · Cited by 10
“It is well published that primary colorectal cancer differs in its biology, depending on sidedness [45].”
BackgroundDas, B., Fehervari, M., Hamrang-Yousefi, S., Jiao, L. R., Pai, M., Jenkins, J. T., & Spalding, D. R. C. (2022) · Colorectal Disease · doi:10.1111/codi.16303 · Cited by 9
“It is known that most sporadic MMR tumours occur in the right side of the colon which present later than left- sided tumours [31], and hence colonic adenocarcinoma requiring PD- RC may be more likely to harbour defective DNA MMR.”
BackgroundLu, C., Lu, C.-T., Chang, K.-Y., Chun-Li, W., & Wu, C.-Y. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02833-4 · Cited by 9
“…right-sided colon can - cer refers to the primary tumors that originate at the cecum, ascending colon, and the first two-thirds of the transverse colon, while left-sided colon cancer refers to tumors in the remaining third of the transverse colon, descending colon, sigmoid colon, and rectum [3].”
BackgroundLi, Y., Eshak, E. S., Cui, R., Shirai, K., Liu, K., Iso, H., Ikehara, S., Tamakoshi, A., Ukawa, S., & JACC Study Group (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.327 · Cited by 9
Prager, G. W., Köhne, C., O’Connor, J. M., Rivera, F., Santini, D., Wasan, H. S., & Phelip, J. (2021) · Current Oncology · doi:10.3390/curroncol28030194 · Cited by 10
“In particular, the location of the primary tumor is now known to affect the outcomes of EGFR-targeted therapies, with left-sided tumors seemingly responding better [19].”
BackgroundAlmuzzaini, B., Alghamdi, J., Alomani, A. A., Alghamdi, S. A. A., Alsharm, A. A., Alshieban, S., Sayed, A., Alhejaily, A., Aljaser, F., Abudawood, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060535 · Cited by 9
“cancers have better prognosis and response to 5-Fluorouracil based and targeted therapies[31].”
BackgroundDank, M., Mühl, D., Herold, M., Hornyák, L., Szász, A. M., & Herold, Z. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164815 · Cited by 10
“Tumors of the cecum, ascending colon, and proximal two-thirds of the transverse colon were defined as right-sided, while tumors originating from the distal one-third of the transverse colon, descending colon, sigmoid colon, and rectum were considered as left-sided [22].”
Background
Metadata
- Authors
- Baran, B., Mert Ozupek, N., Yerli Tetik, N., Acar, E., Bekcioglu, O., & Baskin, Y.
- Affiliations
- Dokuz Eylül University (TR)
- ORCID
- Acar, Emine
- Venue
- Gastroenterology Research
- Publisher
- Elmer Press, Inc.
- Published
- 2018
- Volume
- 11
- Issue
- 4
- Pages
- 264-273
- ISSN
- 1918-2805 (ISSN-L)
- 1918-2813
- PMC
- PMC6089587
- OpenAlex
- W2887365295
- Cited by
- 553
- References
- 113
- Citations by year
- 2026: 62 · 2025: 59 · 2024: 117 · 2023: 76 · 2022: 66 · 2021: 90 · 2020: 56 · 2019: 25 · 2018: 2
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Gastroenterology Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- left-sided colorectal cancer, right-sided colorectal cancer, tumor location, mismatch repair deficiency, chromosomal instability, KRAS mutation, APC mutation, PIK3CA mutation, TP53 mutation, adjuvant chemotherapy, 5-fluorouracil, anti-EGFR therapy, immunotherapy, prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.